Katsuki A - Search Results

1

Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes.

Katsuki A, Sumida Y, Murata K, Furuta M, Araki-Sasaki R, Tsuchihashi K, Hori Y, Yano Y, Gabazza EC, Adachi Y. Katsuki A, et al. Diabetes Obes Metab. 2000 Jun;2(3):189-91. doi: 10.1046/j.1463-1326.2000.00072.x. Diabetes Obes Metab. 2000. PMID: 11220554

2

Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients.

Hori Y, Gabazza EC, Yano Y, Katsuki A, Suzuki K, Adachi Y, Sumida Y. Hori Y, et al. Among authors: katsuki a. J Clin Endocrinol Metab. 2002 Feb;87(2):660-5. doi: 10.1210/jcem.87.2.8214. J Clin Endocrinol Metab. 2002. PMID: 11836301

3

Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus.

Furuta M, Yano Y, Ito K, Gabazza EC, Katsuki A, Tanaka T, Ohtake K, Hirata N, Hori Y, Araki-Sasaki R, Sumida Y, Adachi Y. Furuta M, et al. Among authors: katsuki a. Diabetes Res Clin Pract. 2002 May;56(2):141-5. doi: 10.1016/s0168-8227(01)00358-8. Diabetes Res Clin Pract. 2002. PMID: 11891022

4

Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.

Furuta M, Yano Y, Gabazza EC, Araki-Sasaki R, Tanaka T, Katsuki A, Hori Y, Nakatani K, Sumida Y, Adachi Y. Furuta M, et al. Among authors: katsuki a. Diabetes Res Clin Pract. 2002 Jun;56(3):159-71. doi: 10.1016/s0168-8227(01)00373-4. Diabetes Res Clin Pract. 2002. PMID: 11947963

5

QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus.

Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y. Katsuki A, et al. J Clin Endocrinol Metab. 2002 Jun;87(6):2906-8. doi: 10.1210/jcem.87.6.8592. J Clin Endocrinol Metab. 2002. PMID: 12050271

6

Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus.

Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y. Katsuki A, et al. Eur J Endocrinol. 2002 Jul;147(1):71-5. doi: 10.1530/eje.0.1470071. Eur J Endocrinol. 2002. PMID: 12088922

7

Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus.

Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y. Katsuki A, et al. J Clin Endocrinol Metab. 2002 Nov;87(11):5332-5. doi: 10.1210/jc.2002-020486. J Clin Endocrinol Metab. 2002. PMID: 12414910

8

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.

Yano Y, Kitagawa N, Gabazza EC, Morioka K, Urakawa H, Tanaka T, Katsuki A, Araki-Sasaki R, Hori Y, Nakatani K, Taguchi O, Sumida Y, Adachi Y. Yano Y, et al. Among authors: katsuki a. J Clin Endocrinol Metab. 2003 Feb;88(2):736-41. doi: 10.1210/jc.2002-020691. J Clin Endocrinol Metab. 2003. PMID: 12574207

9

Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance.

Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y. Katsuki A, et al. Diabetes Care. 2003 Aug;26(8):2341-4. doi: 10.2337/diacare.26.8.2341. Diabetes Care. 2003. PMID: 12882859

10

Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.

Katsuki A, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y, Sumida Y. Katsuki A, et al. Eur J Endocrinol. 2004 Nov;151(5):573-7. doi: 10.1530/eje.0.1510573. Eur J Endocrinol. 2004. PMID: 15538935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters